Dr. Matt Kaeberlein is the Chief Executive Officer at Optispan, Inc. and host of the Optispan Podcast. He is
also an Affiliate Professor of Oral Health Sciences at the University of Washington and a Co-Founder of both
the Dog Aging Project and the non-profit 501c3 Dog Aging Institute. He has also co-founded two companies:
Ora Biomedical, a longevity drug discovery biotech and Optispan, Inc. a leading clinical healthcare
technology company. Dr. Kaeberlein is deeply committed to advancing human and animal health by
developing new technologies for health optimization and targeting the biological processes underlying aging
and age-related disease.
A distinguished leader in his field, Dr. Kaeberlein is a Fellow of the American Association for the
Advancement of Science, the American Aging Association, and the Gerontological Society of America. He
has published over 250 scientific papers on longevity and has been honored with numerous prestigious
awards from leading organizations, including the Ellison Medical Foundation, Alzheimer’s Association,
American Federation for Aging Research, Glenn Foundation, Murdock Trust, Puget Sound Business Journal,
and the United States National Institutes of Health and National Institute on Aging. Dr. Kaeberlein is the
founding Director of the University of Washington Healthy Aging and Longevity Research Institute and the
Biological Mechanisms of Healthy Aging Training Program. He served as Director of the NIH Nathan Shock
Center of Excellence in the Basic Biology of Aging, President and Chair of the American Aging Association,
and on the Board of Directors for the Federation of American Societies for Experimental Biology (FASEB). He
currently serves on the Board of Directors for the Alliance for Longevity Initiatives, Ora Biomedical, Inc. and
Optispan, Inc. He is a scientific advisor for several major academic initiatives and companies in the
biotechnology and healthcare industries.